Sept 14 (Reuters) - A serious warning on Pfizer Inc's
quit smoking drug should be removed, 10 of 19
independent panelists to the U.S. Food and Drug Administration
recommended on Wednesday, after reviewing additional trial data
on the controversial treatment.
Read more
No comments:
Post a Comment